Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-idiotype antibodies targeting anti-CD70 chimeric antigen receptor

Anti-idiotype antibodies targeting anti-CD70 chimeric antigen receptor

US Patent 11795238 · Granted Oct 24, 2023

Estimated economic value: $38,520,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods and compositions for treating cancer2025
Systems and methods for rapid assignment of pre-provisioned resources2024
First hop gateway redundancy in a network computing environment2024
Real time popularity based audible content acquisition2024
SID allocation2024
Genetically engineered T cells with Regnase-1 and/or TGFBRII disruption have imp2024
Logical router comprising disaggregated network elements2024
Real time popularity based audible content acquisition2023
Genetically engineered t cells with Regnase-1 and/or TGFBRII disruption have imp2023
Genetically engineered T cells with regnase-1 and/or TGFBRII disruption have imp2023
Methods and compositions for treating cancer2023
Digital chat conversation and virtual agent analytics2023